1 in 4 pediatric corona and MIS-C hospitalized patients persisted for more than 2 months

ⓒ AFP=News1

AD

(Seoul = News 1) Bioreporter Seong Jae-joon = 1 in 4 children and adolescents hospitalized for novel coronavirus infection (COVID-19) or juvenile multisystem inflammatory syndrome (MIS-C) still feel fatigued following 2 months of infection Overseas research results have shown that they are suffering from complications such as

The research team explained that patients with organ failure, pre-existing respiratory disease, or obesity are more likely to suffer from symptoms or activity disorders for a long time.

On the 15th, a research team at the Boston Children’s Hospital of Harvard University School of Medicine announced that more than a quarter of COVID-19 patients admitted to hospitals in the early stages of the COVID-19 outbreak developed symptoms or experienced difficulties in activities for more than 2 to 4 months. The results of this study were published in the international academic journal “Pediatrics” on the 12th.

As one of the ‘Overcoming COVID-19’ studies conducted by the U.S. Centers for Disease Control and Prevention (CDC), the research team conducted 358 patients under the age of 21 who were hospitalized for COVID-19 or MIS-C from May 2020 to May 2021. A survey was conducted on

Of the 279 children and adolescents who responded to the survey, regarding half of COVID-19 patients and 86% of MIS-C patients were hospitalized and treated in the intensive care unit. In addition, 13 acute COVID-19 patients (11%) and 12 MIS-C patients (8%) were readmitted.

As the research team observed hospitalized patients for 2 to 4 months, 26.9% of COVID-19 patients and 30% of MIS-C patients continued to show symptoms or had activity problems.

The most common complication was fatigue or weakness. It was found in 11.3% of COVID-19 inpatients and 20% of MIS-C inpatients. Symptoms were followed by shortness of breath, cough, headache, muscle pain and fever.

Cases of activity disorders that interfere with daily life have also been reported. 6.7% of COVID-19 patients and 14.4% of MIS-C patients were unable to walk or exercise as much as before. In addition, 6.7% of COVID-19 patients and 7.5% of MIS-C patients had a significantly longer bedtime than usual. 4.2% and 3.8% of those who answered that their concentration was so low that they had difficulties in their studies were also found, respectively.

As a result of analyzing the risk factors, the research team estimated that the longer the symptoms of acute COVID-19 had organ failure, the longer the symptoms would last. In addition, among MIS-C patients, patients with existing respiratory diseases such as asthma tended to have persistent symptoms, and obese patients were more likely to experience impaired activity.

Adrienne Randolph, a professor at Boston Children’s Hospital, said that this study was conducted on patients with COVID-19 in the early stages before the delta mutation epidemic. opinion that there is

“It is important to understand how all the different variants affect children and adolescents and to track how effective vaccination is in preventing long-term complications,” said Randolph. .

The research team said, “Almost three-quarters of hospitalized patients recovered to previous levels, but unfortunately regarding a quarter did not. This is much better than hospitalized elderly people, but it is still a worrisome level.” “The risk of this continued is very rare, but it outweighs the risk of complications from the vaccine.”

owner ⓒ ‘Economic News of People Dreaming of Success’ Money S, unauthorized reproduction and redistribution prohibited

Leave a Replay